Disease |
Model |
Genetic Background |
Genetic Mutation |
Induction Method |
Availability Status |
---|---|---|---|---|---|
Obesity |
DIO (B6J) |
C57BL/6J |
n.a. |
HFD |
Yes |
B6-ob |
C57BL/6J |
Lep PM |
n.a. |
Yes |
|
B6-Alms1 mutant |
C57BL/6J |
Alms1 mutation |
n.a. |
Yes |
|
B6-hMC4R |
C57BL/6J |
hMC4R knockin |
n.a. |
2022 Q3 |
|
B6-hGPR75 |
C57BL/6J |
hGPR75 knockin |
n.a. |
2022 Q3 |
|
T2DM |
HFHSD+STZ |
C57BL/6J |
n.a. |
HFHSD+STZ |
Yes |
BKS-db |
BKS |
Lepr PM |
n.a. |
Yes |
|
B6-hGLP-1R |
C57BL/6J |
hGLP-1R knockin |
n.a. |
2022 Q3 |
|
B6-hGCGR |
C57BL/6J |
hGCGR knockin |
n.a. |
2022 Q3 |
|
B6-hGIPR |
C57BL/6J |
hGIPR knockin |
n.a. |
2022 Q3 |
|
B6-Alms1 mutant |
C57BL/6J |
Alms1 mutation |
n.a. |
Yes |
|
Dyslipidemia |
WD Induced (B6J) |
C57BL/6J |
n.a. |
WD |
Yes |
ApoE KO |
C57BL/6J |
Apoe knockout |
n.a. |
Yes |
|
LDLR KO |
C57BL/6J |
Ldlr knockout |
n.a. |
Yes |
|
B6-hPCSK9 |
C57BL/6J |
hPCSK9 knockin |
n.a. |
Yes |
|
B6-hANGPTL2 |
C57BL/6J |
hANGPTL2 knockin |
n.a. |
2022 Q3 |
|
B6-hANGPTL3 |
C57BL/6J |
hANGPTL3 knockin |
n.a. |
2022 Q3 |
|
B6-hANGPTL4 |
C57BL/6J |
hANGPTL4 knockin |
n.a. |
2022 Q3 |
|
B6-hLPA-tg |
C57BL/6J |
hLPA random transgene |
n.a. |
2022 Q4 |
|
B6-hApoC3-tg |
C57BL/6J |
hAPOC3 randome transgene |
n.a. |
2022 Q4 |
|
B6-hApoA1-tg |
C57BL/6J |
hAPOA1 random transgene |
n.a. |
2022 Q4 |
|
B6-hApoB-tg |
C57BL/6J |
hAPOB random transngene |
n.a. |
2022 Q4 |
|
NASH |
HFD+CCl4 |
C57BL/6J |
n.a. |
HFD+CCl4 |
Yes |
BKS-db+WD |
BKS |
Lepr PM |
WD |
Yes |
|
B6-Alms1 mutant+WD |
C57BL/6J |
Alms1 mutation |
WD |
Yes |
|
WD Induced NASH (B6J) |
C57BL/6J |
n.a. |
WD |
Yes |
|
B6-hHSD17B13 |
C57BL/6J |
hHSD17B13 knockin |
n.a. |
2022 Q3 |
|
B6-hPNPLA3 |
C57BL/6J |
hPNPLA3 knockin |
n.a. |
2022 Q3 |
|
Diabetic Nephropathy |
BKS-db; eNOS-/- |
BKS |
Lepr and Nos3 double knockout |
n.a. |
2022 Q4 |
Hyperuricemia |
Uox-KO |
C57BL/6J |
Uox knockout |
n.a. |
2022 Q4 |
Hepatic Fibrosis |
CCl4 |
Any |
n.a. |
CCl4 |
Yes |
Arthritis |
CIA (DBA/1J) |
DBA/1J |
n.a. |
Collagen II |
Yes |
CIA (DBA-hIl17a) |
DBA/1J |
hIl17a knockin |
Collagen II |
Yes |
|
Hemophilia |
F8 KO |
C57BL/6J |
F8 knockout |
n.a. |
Yes |
Osteoporosis |
B6-hRANKL-OPG KO |
C57BL/6J |
hRANKL knockin and Tnfrsf11b knockout |
n.a. |
Yes |
Psoriasis |
IMQ Induced (BALB/c) |
BALB/c |
n.a. |
Imiquimod (5%) |
Yes |
IMQ Induced (BALB/c-hIl17a) |
BALB/c |
hIl17a knockin |
Imiquimod (5%) |
Yes |